Avanos Medical AVNS Diluted (in shares)
Diluted (in shares) at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's diluted (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's diluted (in shares)?
- Avanos Medical (AVNS) reported diluted (in shares) of 47.5M in Q1 2026.
- How has Avanos Medical's diluted (in shares) changed year-over-year?
- Avanos Medical's diluted (in shares) increased by 1.5% year-over-year, from 46.8M to 47.5M.
- What is the long-term trend for Avanos Medical's diluted (in shares)?
- Over 4 years (2021 to 2025), Avanos Medical's diluted (in shares) has grown at a -1.0% compound annual growth rate (CAGR), from 193.3M to 185.8M.
- What does diluted (in shares) mean?
- The average number of common shares outstanding during the period, adjusted for the dilutive impact of all potentially issuable shares such as options, warrants, and convertible securities. This figure is used to calculate diluted earnings per share, providing a conservative view of shareholder ownership.